Altogether, these results suggest that real-time PCR screening of CEACAM5 and HMGB3 can be used to confirm the presence of tumor cells in lung adenocarcinoma specimens of both tissue and lymph node origin, as well as in cDNAs and single-cell or nuclear RNA sequencing libraries. This evidence concerns the gene HMGB3 and lung adenocarcinoma.